bf/NASDAQ:HRTX_icon.jpeg

COM:HERONTX

Heron Therapeutics

  • Stock

Last Close

1.06

22/11 21:00

Market Cap

457.99M

Beta: -

Volume Today

1.34M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
2.67M
-
7.72M
189.29%
24.57M
218.10%
32M
30.24%
33.44M
4.49%
45.14M
35.01%
51.48M
14.03%
48.34M
6.09%
average payables
1.59M
-
2.35M
47.95%
3.39M
44.09%
5.59M
65.25%
13.38M
139.25%
18.00M
34.49%
9.92M
44.88%
1.64M
83.46%
2.16M
31.83%
3.51M
62.38%
3.23M
8.01%
average receivables
980K
-
21.92M
2,136.43%
53.26M
143.02%
52.27M
1.87%
40.86M
21.81%
38.67M
5.36%
43.77M
13.19%
56.09M
28.14%
book value per share
4.27
-
2.37
44.36%
3.57
50.42%
-0.56
115.69%
2.43
533.06%
5.06
108.41%
4.94
2.36%
2.61
47.24%
0.79
69.76%
0.12
84.18%
-245.94
197,396.09%
capex per share
-0.10
-
-0.05
48.08%
-0.03
39.34%
-0.08
151.80%
-0.05
42.85%
-0.13
165.22%
-0.09
30.18%
-0.08
14.20%
-0.03
59.11%
-0.02
45.38%
-11.18
66,625.84%
capex to depreciation
-5.06
-
-2.49
50.83%
-1.48
40.53%
-2.85
92.80%
-1.67
41.54%
-6.06
263.50%
-3.50
42.26%
-2.39
31.63%
-1.00
58.20%
-0.63
36.85%
-0.53
15.63%
capex to operating cash flow
0.04
-
0.02
42.29%
0.01
42.02%
0.02
69.04%
0.01
35.88%
0.05
218.95%
0.06
20.10%
0.04
35.81%
0.01
59.69%
0.01
16.41%
0.03
111.56%
capex to revenue
-2.45
-
-0.08
96.61%
-0.12
42.66%
-0.05
58.60%
-0.08
56.83%
-0.03
54.47%
-0.02
51.57%
-0.01
52.56%
cash per share
4.47
-
2.74
38.84%
3.96
44.95%
1.35
65.99%
3.19
136.57%
4.54
42.36%
4.78
5.28%
2.30
51.96%
1.60
30.33%
0.78
51.30%
582.10
74,591.47%
days of inventory on hand
55.69K
-
804.15
98.56%
517.84
35.60%
147.90
71.44%
422.65
185.77%
383.73
9.21%
363.00
5.40%
118.04
67.48%
days payables outstanding
81.90K
-
1.50K
98.16%
226.69
84.94%
16.34
92.79%
5.30
67.59%
30.16
469.62%
21.45
28.88%
9.08
57.66%
days sales outstanding
559.34
-
496.77
11.19%
304.59
38.69%
99.72
67.26%
172.33
72.82%
150.06
12.92%
176.44
17.58%
114.23
35.26%
debt to assets
0.01
-
0.02
54.39%
0.02
22.65%
0.78
4,764.13%
0.12
84.39%
0.01
91.92%
0.04
290.01%
0.07
80.35%
0.52
649.50%
0.63
20.28%
0.81
28.65%
debt to equity
0.01
-
0.03
70.45%
0.02
25.76%
-2.49
13,334.55%
0.22
108.79%
0.01
94.35%
0.05
296.62%
0.10
112.34%
2.06
1,875.79%
11.60
464.31%
-5.29
145.57%
dividend yield
earnings yield
-0.38
-
-0.29
24.82%
-0.11
61.33%
-0.35
215.42%
-0.20
42.07%
-0.09
53.35%
-0.11
13.11%
-0.12
9.65%
-0.24
107.25%
-0.49
104.13%
-470.81
95,166.38%
enterprise value
74.20M
-
196.21M
164.41%
810.30M
312.98%
536.31M
33.81%
862.23M
60.77%
1.87B
117.04%
1.87B
0.09%
1.84B
1.55%
967.99M
47.41%
414.30M
57.20%
151.19M
63.51%
enterprise value over ebitda
-1.36
-
-2.63
93.12%
-8.36
217.69%
-3.14
62.47%
-4.49
43.10%
-10.17
126.57%
-8.96
11.92%
-8.07
9.97%
-4.44
44.92%
-2.37
46.62%
-1.37
42.38%
ev to operating cash flow
-1.82
-
-3.25
78.80%
-10.32
217.04%
-4.00
61.24%
-5.06
26.59%
-9.76
92.70%
-15.01
53.82%
-9.96
33.64%
-4.76
52.20%
-2.82
40.76%
-2.57
8.81%
ev to sales
419.32
-
28.02
93.32%
24.15
13.81%
12.81
46.97%
20.77
62.12%
11.21
46.02%
3.85
65.68%
0.79
79.55%
free cash flow per share
-2.63
-
-2.32
11.55%
-2.41
3.60%
-3.62
50.36%
-3.20
11.60%
-2.75
14.16%
-1.61
41.33%
-2.11
31.05%
-2.10
0.72%
-1.37
34.82%
-436.78
31,872.13%
free cash flow yield
-0.29
-
-0.23
20.87%
-0.09
60.97%
-0.28
206.46%
-0.18
36.02%
-0.11
40.10%
-0.07
35.24%
-0.10
45.51%
-0.23
130.14%
-0.55
138.05%
-256.93
46,917.83%
graham net net
4.04
-
2.22
44.98%
3.37
51.55%
-0.88
126.19%
1.96
321.66%
4.21
115.46%
3.97
5.84%
1.58
60.08%
-0.20
112.66%
-0.79
294.95%
-795.69
100,395.90%
graham number
18.12
-
12.39
31.62%
15.39
24.25%
7.59
50.72%
14.13
86.19%
16.67
18.04%
16.68
0.03%
12.04
27.82%
6.26
48.01%
1.86
70.26%
2.10K
112,953.37%
income quality
0.74
-
0.79
7.06%
0.80
1.93%
0.77
3.75%
0.86
11.34%
1.07
24.37%
0.61
43.27%
0.81
33.65%
0.92
13.32%
0.81
12.41%
0.53
34.12%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
-65.93
-
-84.06
27.50%
-101.17
20.36%
-64.16
36.59%
-49.42
22.97%
-68.84
39.30%
-143.13
107.93%
-120.02
16.15%
-90.39
24.69%
-70.60
21.89%
28.60
140.51%
interest debt per share
0.11
-
0.09
18.33%
0.10
2.78%
1.47
1,424.42%
0.60
58.81%
0.10
83.60%
0.26
162.65%
0.29
12.33%
1.64
462.95%
1.47
10.65%
1.27K
86,508.70%
inventory turnover
0.01
-
0.45
6,825.19%
0.70
55.29%
2.47
250.13%
0.86
65.01%
0.95
10.14%
1.01
5.71%
3.09
207.52%
invested capital
0.01
-
0.03
70.45%
0.02
25.76%
-2.49
13,334.55%
0.22
108.79%
0.01
94.35%
0.05
296.62%
0.10
112.34%
2.06
1,875.79%
11.60
464.31%
-5.29
145.57%
market cap
145.47M
-
267.28M
83.74%
883.26M
230.46%
496.82M
43.75%
978.12M
96.88%
1.90B
94.11%
1.92B
1.22%
1.92B
0.03%
899.04M
53.21%
272.19M
69.72%
234.83K
99.91%
net current asset value
65.93M
-
60.11M
8.83%
115.02M
91.34%
-26.59M
123.12%
124.89M
569.70%
355.23M
184.43%
370.12M
4.19%
197.13M
46.74%
26.29M
86.67%
-31.94M
221.52%
-67.70M
111.95%
net debt to ebitda
1.31
-
0.95
27.15%
0.75
21.04%
-0.23
130.70%
0.60
361.19%
0.15
75.44%
0.25
68.49%
0.35
41.33%
-0.32
189.69%
-0.81
157.04%
-1.36
67.72%
net income per share
-3.42
-
-2.87
15.96%
-2.95
2.64%
-4.57
54.76%
-3.65
19.95%
-2.44
33.14%
-2.50
2.47%
-2.47
1.25%
-2.21
10.60%
-1.24
44.11%
-800.37
64,681.14%
operating cash flow per share
-2.52
-
-2.27
10.04%
-2.37
4.62%
-3.54
48.96%
-3.15
10.87%
-2.62
16.84%
-1.52
41.87%
-2.04
33.65%
-2.07
1.43%
-1.35
34.66%
-425.59
31,440.40%
payables turnover
0.00
-
0.24
5,341.75%
1.61
563.87%
22.34
1,287.60%
68.93
208.53%
12.10
82.44%
17.02
40.61%
40.19
136.19%
receivables turnover
0.65
-
0.73
12.60%
1.20
63.09%
3.66
205.45%
2.12
42.14%
2.43
14.84%
2.07
14.95%
3.20
54.46%
research and ddevelopement to revenue
80.63
-
4.50
94.41%
1.81
59.87%
1.15
36.56%
1.97
71.71%
1.52
23.06%
1.00
34.10%
0.29
70.86%
return on tangible assets
-0.73
-
-1.00
36.80%
-0.71
28.91%
-2.57
262.41%
-0.84
67.15%
-0.39
54.09%
-0.40
3.19%
-0.63
58.98%
-0.71
12.16%
-0.54
24.72%
-0.50
7.30%
revenue per share
0.03
-
0.57
1,588.20%
1.06
85.92%
1.78
68.63%
0.98
45.29%
0.88
10.20%
0.99
12.78%
1.39K
140,557.78%
roe
-0.80
-
-1.21
51.03%
-0.83
31.77%
8.15
1,086.06%
-1.51
118.48%
-0.48
67.92%
-0.51
4.94%
-0.95
87.18%
-2.81
195.68%
-9.91
253.22%
3.25
132.83%
roic
-0.77
-
-1.14
47.93%
-0.80
30.14%
-5.36
571.01%
-1.24
76.86%
-0.51
58.74%
-0.48
6.03%
-0.81
68.00%
-0.87
7.37%
-0.72
17.05%
-0.73
1.37%
sales general and administrative to revenue
16.71
-
0.83
95.03%
0.38
54.52%
0.26
31.26%
0.48
83.49%
0.47
2.39%
0.35
25.23%
0.26
26.64%
shareholders equity per share
4.27
-
2.37
44.36%
3.57
50.42%
-0.56
115.69%
2.43
533.06%
5.06
108.41%
4.94
2.36%
2.61
47.24%
0.79
69.76%
0.12
84.18%
-245.94
197,396.09%
stock based compensation to revenue
20.29
-
0.99
95.11%
0.43
56.61%
0.35
18.22%
0.57
60.86%
0.54
4.23%
0.40
26.43%
0.17
57.17%
tangible asset value
68.94M
-
63.06M
8.53%
118.11M
87.29%
-21.25M
117.99%
131.14M
717.08%
370.16M
182.27%
403.83M
9.10%
236.49M
41.44%
77.57M
67.20%
13.57M
82.50%
-33.97M
350.32%
tangible book value per share
4.27
-
2.37
44.36%
3.57
50.42%
-0.56
115.69%
2.43
533.06%
5.06
108.41%
4.94
2.36%
2.61
47.24%
0.79
69.76%
0.12
84.18%
-245.94
197,396.09%
working capital
65.93M
-
60.11M
8.83%
115.02M
91.34%
23.41M
79.65%
124.89M
433.50%
355.23M
184.43%
382.36M
7.64%
211.69M
44.64%
183.37M
13.38%
123.08M
32.88%
109.09M
11.37%

All numbers in (except ratios and percentages)